High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
Recruiting · NCT04221035 · Registry updated 2025-06-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN) | High-Risk Neuroblastoma; Patient With Insufficient Response Chemoimmunotherapy | Recruiting | Phase 3 | 2025-06-26 | NCT04221035 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Gustave Roussy, Cancer Campus, Grand Paris | 93 |
142 results · Page 1 of 6
Research sites
Swipe the table sideways for more columns.